Evidence map›Paper›PMID 23619274›Full record

GuidelineGenetics in medicine : official journal of the American College of Medical Genetics2013

American College of Medical Genetics and Genomics technical standards and guidelines: microarray analysis for chromosome abnormalities in neoplastic disorders.

Linda D Cooley, Matthew Lebo, Marilyn M Li, Marilyn L Slovak, Daynna J Wolff, Working Group of the American College of Medical Genetics and Genomics (ACMG) Laboratory Quality Assurance Committee

Abstract readPractice Guideline
PubMed Publisher
In one paragraph

Guideline in Genetics in medicine : official journal of the American College of Medical Genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Article
  3. Frontiers in oncology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Semiconductor Sequencing Analysis of Chromosomal Copy Number Variations in Spontaneous Miscarriage.Medical science monitor : international medical journal of experimental and clinical research · 2017
    Article
  15. Article
  16. Article
  17. Article
  18. Cancer cytogenetics: methodology revisited.Annals of laboratory medicine · 2014
    Review
  19. Article
  20. 5'Case reports in oncology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Linda D CooleyDepartment of Pathology and Laboratory Medicine, Children's Mercy Hospital and University of Missouri Medical School, Kansas City, Missouri, USA. lcooley@cmh.edu
Matthew Lebo
Marilyn M Li
Marilyn L Slovak
Daynna J Wolff
Working Group of the American College of Medical Genetics and Genomics (ACMG) Laboratory Quality Assurance Committee

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microarray methodologies, to include array comparative genomic hybridization and single-nucleotide polymorphism-based arrays, are innovative methods that provide genomic data. These data should be correlated with the results from the standard methods, chromosome and/or fluorescence in situ hybridization, to ascertain and characterize the genomic aberrations of neoplastic disorders, both liquid and solid tumors. Over the past several decades, standard methods have led to an accumulation of genetic information specific to many neoplasms. This specificity is now used for the diagnosis and classification of neoplasms. Cooperative studies have revealed numerous correlations between particular genetic aberrations and therapeutic outcomes. Molecular investigation of chromosomal abnormalities identified by standard methods has led to discovery of genes, and gene function and dysfunction. This knowledge has led to improved therapeutics and, in some disorders, targeted therapies. Data gained from the higher-resolution microarray methodologies will enhance our knowledge of the genomics of specific disorders, leading to more effective therapeutic strategies. To assist clinical laboratories in validation of the methods, their consistent use, and interpretation and reporting of results from these microarray methodologies, the American College of Medical Genetics and Genomics has developed the following professional standard and guidelines.

Indexed as

Chromosome AberrationsGenomicsHumansNeoplasmsOligonucleotide Array Sequence AnalysisReproducibility of ResultsSoftware

Identifiers

PMID23619274

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.